Contact Us: 86 -21- 61573919     Add to Calendar    /    中文   /   English   

 
   

Do you want to stand out from dynamic generics competition and innovator pharma's entry?

There are major shifts in the approach to the future opportunities for generic drugs:
·Global regulatory guidelines change.
·Blockbuster drug patents expire and IP infringements increase.
·Innovator Pharmas enter into generics market by M&A, strategic alliance and other partnerships.
·Innovative technology evolves in generics R&D and commercialization.
·Biosimilar is on emerging market.
These shifts have provided immens
  Figures and Facts for Generics

·In China, generic drugs have a total market share of 97%.
·The peak of patent expiries will impact the key developed markets mostly in 2012.
·In 2011-2015, patent drugs with a value of over $77 billions are about to expire.
·The global generics market is estimated at about $225 billion in 2011. By 2016, it is expected that the value of the total global generics sector will have risen to $358 billion.
Who Should Attend
CEOs, VPs, Directors, GMs, and Heads of: Business Development and Strategy, Product Development, Pharmaceutical Development, Sales & Marketing, R&D, Formulation, QA/QC, Clinical Research, In-Licensing, Out-Licensing, Regulatory Affairs, IPR from:
 

From
Government agencies,Generic Manufacturers,Innovator Pharma Manufacturers,Biopharma Manufacturers,Life Sciences Companies,Drug Delivery Platform Providers,CRAMS,Analytical Laboratories,Ingredient and Material Suppliers,Machinery Manufacturers

  HOT TOPICS
  Regulatory   Market    Technology
·ANDA Updates and Generics Access in Assurance System
·EU Healthcare Policy for Generics and Submission Procedure
·SFDA (CTD) Format for Generics
·Japan, India Regulatory System on Generics
·Global and China Profitable Generics Landscape
·Case Study: India Generic Drugs Development and Access and Penetration to USA and EU Market
·Big Pharma’s IP Strategy, M&A prospect, strategic alliance, biosimilar strategy, etc.
·New Formulation Technology and Strategy as Product Differentiation Strategy to Win the Competition: Controlled/Sustained, lipsome, nano technology, etc.
·Impurities Research Methodology for Generic Drugs to Improve Quality

more     

more     

more     

   
  7 Compelling Reasons to Attend

·Delving into key trends of generics regulatory, market and technology
·Hearing in-depth presentations from 25+ global speakers under CPhI resources
·Getting on-spot answers to your critical business and technical challenges from 10+ Q&A sessions
·Covering 3 hot topics: updated regulatory environment, ever-changing market and alliance, evolving technology and commercialization
·Networking with and 120+ decision makers from 30+ China’s pharmaceutical companies and 20+ MNCs from Asia Pacific, America, Europe, etc.
·Brainstorming with industry leaders in 2 workshop and 2 leaders’ think tank
·Benefiting from case studies from leading generic pharma

Subscribe Enews Here

Organised by

Sponsors

Media Supports

Contact Us

Registration | FAQS | Download | Contact Us | About Us | Terms& Conditions | Privacy Policy
Contact: Tel:86 21 61573930 Fax:86 21 61577299 Email:conferencechina@ubm.com Add:9F, Ciros Plaza, No.388 West Nanjing Road, Shanghai 200003
© Copyright ©UBM 2011-2012, All Rights Reserved